Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience-Reference-Cited by-同舟云学术

Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience

Published:2012 Issue:12 Volume:35 Page:740-745
ISSN:1423-0240
Container-title:Onkologie
language:en
Short-container-title:Onkologie

Author:

Cetin Bulent,Benekli Mustafa,Oksuzoglu Berna,Koral Lokman,Ulas Arife,Dane Faysal,Turker Ibrahim,Kaplan Mehmet A.,Koca Dogan,Boruban Cem,Yilmaz Burcak,Sevinc Alper,Berk Veli,Isikdogan Abdurrahman,Uncu Dogan,Harputluoglu Hakan,Coskun Ugur,Buyukberber Suleyman

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference19 articles.

1. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

2. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma

3. Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer

4. Trastuzumab in CSF

5. Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood–brain barrier

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation-induced cognitive toxicity in era of precision oncology – from pathophysiology to strategies for limiting toxicities;Česká a slovenská neurologie a neurochirurgie;2023-10-31

2. Advancing outcomes of metastatic HER2-positive breast cancer;The Lancet;2023-05

3. Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis;Pharmaceuticals;2023-03-30

4. Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis;Cancers;2022-11-15

5. Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance;Frontiers in Pharmacology;2022-04-01